Date Title Description PDF
23 Feb 2022 On business and financial situation The Company releases the press release related to the full year 2021 financial results Download
23 Feb 2022 On business and financial situation The Company releases the full year 2021 financial results presentation Download
23 Feb 2022 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
22 Feb 2022 On buy-back programmes ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.     Download
16 Feb 2022 On business and financial situation Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years       Download

Pages

Date Title Description PDF
31 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 24 May and 30 May 2024 Download
24 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 17 May and 23 May 2024 Download
21 May 2024 Announcement of general shareholders’ meeting Publication of the announcement of the call to the General Shareholders’ Meeting and the documentation related thereto.   Download
17 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 10 May and 16 May 2024 Download
10 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 2 May and 9 May 2024 Download

Pages

Date Title Description PDF
21 Feb 2013 Información sobre resultados (2) Download
21 Feb 2013 Información sobre resultados Download
21 Feb 2013 Informe Anual de Gobierno Corporativo 2012 Download
08 Nov 2012 Información financiera intermedia Download
08 Nov 2012 Información sobre resultados Download

Pages